Susan Keiler, MD
Dermatology · Sheboygan, WINPI 1063602811
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Bristol Myers Squibb at 35.1% of the total. Reporting peaked in 2019 at $18,147 and has fallen 73.6% since, to $4,793 in 2025. Among dermatology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,600 payments — averaging $27.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$16K
- Amgen$7K
- AbbVie$4K
- UCB, Inc.$2K
- Regeneron Healthcare Solutions, Inc.$2K
- Novartis$2K
- plus $13K from 32 others
What the payments were for
- Consulting fees$4581%
- Speaking & faculty fees$17,79440%
- Travel & lodging$1,7924%
- Food & beverage$23,39253%
- Education$7502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$44,185 in reported general payments places this provider in the 95th percentile of 260 dermatology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 62 | $237,855 |
| Tacrolimus | 40 | $4,832 |
| Clobetasol Propionate | 125 | $4,339 |
| Ketoconazole | 311 | $4,276 |
| Pimecrolimus | 22 | $3,956 |
| Metronidazole | 43 | $2,523 |
| Clindamycin Phosphate | 81 | $1,859 |
| Fluorouracil | 19 | $1,562 |
| Tretinoin | 11 | $1,516 |
| Triamcinolone Acetonide | 199 | $1,191 |
| Ciclopirox | 32 | $830 |
| ValacyclovirValacyclovir Hcl | 32 | $782 |
| Doxycycline Monohydrate | 37 | $687 |
| Fluocinolone AcetonideFluocinolone/Shower Cap | 13 | $668 |
| Mometasone Furoate | 38 | $591 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Sheboygan
- Daniel OpelSheboygan$118K
- Aloys TauscheckSheboygan$8K
- David NelsenJanesville$1.1M
- Gabriela MaloneyOconomowoc$725K
- Kenneth GordonWauwatosa$577K
- Ashley DietrichMilwaukee$466K
- Martin OkunFort Atkinson$232K
- Betsy WernliManitowoc$177K
- Stephen LewellisPlover$73K
- Patrick SafoStevens Point$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.